Clinical Trial Concludes Transcatheter Aortic Valve Replacement Can Be Considered for Patients in All Surgical Risk Classes
American Association for Thoracic Surgery (AATS)A new clinical trial finds transcatheter aortic valve replacement (TAVR) to be equivalent or potentially preferable to surgical aortic valve replacement (SAVR) for low risk patients.